Forty Seven Inc. to Present at 2019 Cantor Global Healthcare Conference

NEXT STORY
XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain
PREV STORY
Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy

author_avatar
NASDAQ Market News

7 Hills Pharma Announces FDA Clearance of Investigational New Drug Application for 7HP349, a First-in-Class Immune Stimulant 

author_avatar
NASDAQ Market News

135,000 Orion Corporation A shares converted into B shares

author_avatar
NASDAQ Market News